Cerebras Stock Craters 16% as AI Chip Reality Meets Wall Street Expectations

Cerebras Holdings discovered what the market has been learning in painful increments since the AI boom began: the gap between hype and actual unit economics is where fortunes evaporate. The specialty inference chip maker's shares fell 16% in extended trading following its second earnings report as a public company, a particularly uncharitable reception given that the firm had just raised full-year guidance and announced a multi-year deal with OpenAI valued at more than $20 billion.

The numbers tell the story. Cerebras reported a net loss of $450.5 million in the quarter, a stunning reversal from the $309.5 million profit it posted a year earlier. Strip away the noise of $386.6 million in stock-compensation costs—a figure so large it nearly accounts for the entire loss—and you're left with a company burning capital at a rate that makes even venture capitalists nervous. The firm went public in May, raising $6.4 billion, and walked out with guidance suggesting it had solved the profitability puzzle. The market apparently disagreed.

Revenue did climb 74 percent year-over-year to $180.1 million, which would be encouraging if sequential growth hadn't flatlined. Cerebras guided Q2 core revenue at approximately $194 million, compared to $193.4 million in Q1. That's essentially nothing. In Q1, the company had delivered 92 percent year-over-year growth. The deceleration from growth stock to stability narrative happened in one quarter, which is precisely when investors tend to reassess their thesis and reach for the sell button.

CEO Andrew Feldman told analysts that AI demand is "through the roof" and that customers are paying premium rates for the company's specialty inference chips. The OpenAI agreement certainly supports that claim—750 megawatts of Cerebras inference computing capacity represents serious revenue for years to come. AWS also signed on for a multi-year partnership involving Cerebras' CS-3 systems handling decoding while AWS's Trainium 3 chips manage prefill processing. These are not small partnerships. They are, in fact, the kind of deals that typically justify a stock price bump.

What investors heard instead was a warning. Growth is decelerating. Losses are widening. Stock compensation is consuming profits that should theoretically be flowing to shareholders. The company guided toward 38 to 40 percent core gross margins in Q2, which is respectable, but margin expansion becomes irrelevant if revenue growth has downshifted into first gear.

This is the eternal story of growth companies discovering the mathematics of scale. You can raise $20 billion in partnership commitments. You can expand gross margins. You can position yourself as the indispensable chip vendor to the largest AI companies on Earth. But if sequential revenue growth stalls while operating losses expand, the market will remind you that hype is not a substitute for cash flow. Cerebras closed Wednesday at $262.06, up 42 percent from its May IPO price. After today's decline, do not be surprised to see analysts updating spreadsheets and revising assumptions about when—or if—this company reaches profitability.